A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with alzheimer disease

Joel E. Streitn, Anton P. Porsteinsson, Christopher D. Breder, Rene Swanink, Ronald Marcus, Robert McQuade, William H. Carson

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with alzheimer disease'. Together they form a unique fingerprint.

Medicine & Life Sciences